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Agreement in Walking Speed Measured Using Four Different Outcome Measures:
6-Meter Walk Test, 10-Meter Walk Test, 2-Minute Walk Test, and 6-Minute Walk
Test
Abstract
Background: Walking speed is considered the sixth vital sign because it is a valid, reliable, and sensitive
measure for assessing functional status in various populations. Purpose: The current study assessed
agreement in walking speed using the 6-meter walk test, (6MWT) 10-meter walk test (10MWT), 2-minute
walk test (2minWT), and 6-minute walk test (6minWT). We also determined differences in walking speed.
Methods: Seventy-three healthy adults (44 females, 29 males; mean [SD] age=31.36 [10.33] years)
participated. Lafayette Electronic timing devices measured walking speed for the 6MWT and 10MWT.
Measuring wheels and stopwatches measured walking distance and speed for the 2minWT and 6minWT.
Participants completed 1 trial, and all tests were administered simultaneously. Results: The intraclass
correlation coefficient (2, 4) for the different measures of walking speed was excellent at 0.90 (95%
confidence intervals, 0.86-0.93). The correlation was 0.95 between 6MWT and 10MWT, 0.94 between
2minWT and 6minWT, 0.67 between 6MWT and 2minWT, 0.63 between 10MWT and 2minWT, and 0.59
between 10MWT and 6minWT (all p < 0.05). No differences in walking speed were found between the four
walking tests. Conclusion: Administration of any of the four walking tests provided reliable measurement
of walking speed.
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ABSTRACT
Background: Walking speed is considered the sixth vital sign because it is a valid, reliable, and sensitive measure for assessing
functional status in various populations. Purpose: The current study assessed agreement in walking speed using the 6-meter walk
test, (6MWT) 10-meter walk test (10MWT), 2-minute walk test (2minWT), and 6-minute walk test (6minWT). We also determined
differences in walking speed. Methods: Seventy-three healthy adults (44 females, 29 males; mean [SD] age=31.36 [10.33] years)
participated. Lafayette Electronic timing devices measured walking speed for the 6MWT and 10MWT. Measuring wheels and
stopwatches measured walking distance and speed for the 2minWT and 6minWT. Participants completed 1 trial, and all tests were
administered simultaneously. Results: The intraclass correlation coefficient (2, 4) for the different measures of walking speed was
excellent at 0.90 (95% confidence intervals, 0.86-0.93). The correlation was 0.95 between 6MWT and 10MWT, 0.94 between
2minWT and 6minWT, 0.67 between 6MWT and 2minWT, 0.63 between 10MWT and 2minWT, and 0.59 between 10MWT and
6minWT (all p < 0.05). No differences in walking speed were found between the four walking tests. Conclusion: Administration of
any of the four walking tests provided reliable measurement of walking speed.
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INTRODUCTION
Walking ability is an important risk factor for morbidity and mortality in community-dwelling adults.1 Walking speed is considered a
sixth vital sign because it is a valid, reliable, and sensitive measure for assessing functional status and health in a wide range of
populations.1,2 It is also a key component of evaluation in a variety of physical therapy practice settings and provides valuable
information about function, quality of life, and how to improve the outcomes and care of patients2. As walking speed is an important
indicator of a person's health status, it can be used to monitor changes during routine health care visits.
Walking speed has been assessed in a variety of patient populations, including older adults and those with stroke, Parkinson’s
disease, Alzheimer’s disease, hip fracture, and knee osteoarthritis.3,4 A slow walking speed is one of the five criteria to describe
frailty.5 Further, frailty is associated with physiological alterations, such as inflammation, glucose metabolism, and coagulation, and
it can lead to abnormal neuromuscular function and a decrease in functional reserve of every organ system.6,7 Normal walking
speed is considered to be between 1.1 m/s and 1.3 m/s (between 2.6 mph and 3.1 mph).3,4,8 It has been correlated with an increase
in quality of life, and individuals who are community ambulators tend to have a significantly better quality of life than nonambulators.8
Evidence supports the use of usual gait speed, time, or distance covered during walking performance tests, as predictors of
mortality and potential cardiovascular events.9-14 In one study, a natural walking speed of 0.82 m/s was most predictive of early
mortality, and older men who walked faster than this cutoff speed were 1.23 times less likely to die than those who walked at slower
speeds.15 Researchers have suggested that slower walking speed may be associated with greater severity of unhealthy conditions
that are linked to mortality, such as cardiovascular disease and cancer.1 Therefore, walking speed is an important clinical measure
to consider in multiple patient populations.
In multiple patient populations, walking speed can be assessed using a variety of tools, including the 6-meter walk test (6MWT),
10-meter walk test (10MWT), 2-minute walk test (2minWT), and 6-minute walk test (6minWT). These tools have high test-retest
reliability and high interrater and intrarater reliability; however, each test has space requirements for completion and uses different
measuring devices. For example, a hospital hallway may be used to measure the 6MWT, but an outpatient or home health practice
setting may have limited space and level walking ground. Several studies have measured the 6MWT by asking participants to walk
up and down a hallway of a specific length, which allows for the performance of the test in a setting with less area.16,17 The design
of these walking tests did not include any turns as this involves periods of deceleration when approaching a turn and then
reacceleration after the turn thus affecting overall speed. This modification may be problematic as the total number of turns
influences the walking speed and distance covered in 6 minutes. For patients with neurological disorders, some have
recommended that the 6MWT be performed on a rectangular walkway.18-20 Others have investigated whether course length affects
walking speed, but all of these studies have investigated clinical populations and not healthy individuals.21,22
The 10MWT, 2minWT, and 6minWT have shown strong correlations in a variety of diseases or impairments,3,4 which suggests
agreement between measures since both types (length vs time) appear to provide similar information about walking ability.
Although there is ample literature indicating a connection between walking speed and various diseases and impairments, little
evidence exists supporting the correlation of walking speed in healthy adults with the various measurement tools. Therefore, the
purpose of the current study was to assess agreement in walking speed as measured using the 6MWT, 10MWT, 2minWT, and
6minWT. A secondary purpose was to determine differences in walking speed using these four different measures.
MATERIALS AND METHODS
Study Design
The current study used a quasi-experimental, repeated measures design. Outcome measures included time to complete the 6MWT
and 10MWT and the distance covered during the 2minWT and 6minWT. A sample size analysis indicated that 73 participants
would be required for a power of at least 0.80 to identify an effect size = 0.7; all α = .01, two-tailed.
Procedures
The A.T. Still University institutional review board approved the study (#2018-014). All participants were informed of the benefits
and risks of the study before signing an institutionally approved informed consent document to participate.
Subjects
Potential participants were recruited via flyers and word-of-mouth from a health sciences university. Participants were included in
the study if they were aged between 21 and 65 years, had sufficient English proficiency to follow simple instructions for testing,
and were able to ambulate independently for a minimum of 150 feet (45.72 meters) without the use of an assistive device. The
© The Internet Journal of Allied Health Sciences and Practice, 2021
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Iowa Level of Assistance Scale was used to define independence, so the participant had to be able to perform the activity safely
without the supervision of another individual in the room. Exclusion criteria were lower extremity surgery within the past year, lowerextremity amputation within the past year, diagnosis of a neurologic condition, such as Parkinson’s disease, or stroke with lower
extremity involvement. Age, height in centimeters, and weight in kilograms of all participants were recorded, and body mass index
(BMI) was calculated. Before and after the walking tests, heart rate and blood pressure were recorded using a standardized
approach suggested by Frese et al.23
Instrumentation
An outside walking course was used in the current study. All four measures for walking speed were determined sequentially. For
the 6 and 10 meter walking tests, the participant was instructed to walk at a self-selected speed, and the velocity was calculated
as distance divided by time.24 For the 2 and 6 minute walking tests, the participant was instructed to walk at a comfortable speed
over a flat and straight surface.25-27
The 6MWT is an activity-level domain measure that is highly correlated with functional status; it requires a flat and straight 10meter length walkway without turns.28,29 In the current study, the 6-meter course was mapped as 10 meters in length with a 2meter acceleration interval and a 6-meter testing interval. Two Lafayette Instrument Company Model 63501IR infrared sensors
were connected to a Lafayette Instrument Company Model 54060 timing device. Masking tape was placed at the zero (0) meter
point of the walking course. One sensor was placed at the 2-meter acceleration point. This sensor triggered the timing device to
start recording. The other sensor was placed at the 6-meter acceleration point and was set up to stop the timing device and record
the time.
Like the 6MWT, the 10MWT is also an activity-level domain measure, but it requires a flat and straight 20-meter length walkway
without turns. The first and last 5 meters are used to accelerate and decelerate, and only the middle 10 meters are recorded. In
the current study, the 10-meter course was mapped as 20 meters in length with a 5-meter acceleration interval and a 10-meter
testing interval. As above, two infrared sensors were connected to a timing device. Masking tape was placed at the zero (0) meter
point of the walking course. One sensor was placed at the 5-meter acceleration point. This sensor triggered the timing device to
start recording. The other sensor was placed at the 15-meter acceleration point and was set up to stop the timing device and record
the time.
The 2minWT is a reliable and valid measure that reports the distance walked during a 2-minute walk. For the current study, at the
end of the 15-meter portion of the course for the 10MWT, an investigator walked with the participant for two minutes. An Accusplit
Pro 601X survivor stopwatch was used to measure the time. The investigator then used a Keson Metal Professional measuring
wheel to measure the distance in meters.
The 6minWT is an activity-level domain test that measures the longest distance walked in 6 minutes. Like the 2minWT, at the 15meter end of the walking course for the 10MWT, an investigator walked with the participant for six minutes. Time was recorded
with a stopwatch, and the distance was measured in meters with a measuring wheel.
The outcome measure used in the current study was the Iowa Level of Assistance Scale (ILAS). The ILAS grades the level of
assistance according to the number of points of therapist physical contact to walk or perform tasks safely. The ILAS is a valid and
reliable tool for patients with orthopedic conditions.30,31
Data Collection
Participants started the walking tests at the zero marcation on the walking course. They were instructed to begin walking at a
comfortable walking speed through the mapped course. Data were recorded for all four tests sequentially, so participants were told
to not stop until they had walked through the entire course. Each participant completed one trial. After the trial, the primary
investigator recorded the time from the infrared sensor. Doctorate physical therapy students recorded the distance walked for the
2minWT and 6minWT with a Keson Metal Professional measuring wheel of each participant and calculated the walking speed in
cm/sec. All testing was conducted when the outside temperature was between 70°F and 90°F (21°C and 32°C).
Statistical Analyses
Means and standard deviations (SD) were calculated for age, height, weight, BMI, walking time for the 2MWT and 10MWT, and
walking distance for the 2minWT and 6minWT. Walking speeds were then calculated as walking distance divided by walking time
and are reported as cm/s. Pearson product-moment correlation coefficients were calculated to determine the relationship between
the four different measures of walking speed. An intraclass correlation coefficient (ICC), model 2 (as the same rater was used for
all four measures)(ICC), and a 95% confidence interval (CI) was calculated to determine the agreement between the measures of
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walking speed. The significance level was set at an α of 0.05. If the correlations were considered high, Bland-Altman plots were
used to observe the agreement in outcomes between the different measures of walking speed. Microsoft Excel (Redmond, WA)
and SPSS statistical software version 23.0 (IBM, Chicago, IL) were used for data collection and analysis.
RESULTS
The demographic characteristics of the study participants are reported in the Table. Thirty male and 44 female graduate students
from the health sciences university participated in the current study. Age ranged between 21 and 35 years; mean [SD]
age=31.36 [10.33] years. Calculated walking speed for the four different measures of walking speed is reported in Figure 1.
Because there was an overlap of the intervals for the four tests, we deduced there were no differences in walking speed between
the two sexes and the four different measures. The Iowa Level of Assistance score was zero for all participants as no assistance
was needed for the participants.
Table. Demographic characteristics and walking test outcomes of study participants
Variable
Mean (SD)
Male (n = 30)
Age, y
30.83 (7.32)
Height, cm
178.79 (7.59)
Weight, kg
86.94 (20.10)
Body mass index
27.02 (4.42)
6-Meter walk test time, s
3.83 (0.42)
10-Meter walk test time, s
6.61 (0.68)
2-Minute walk test distance, m
180.81 (13.41)
6-Minute walk test distance, m
541.04 (36.84)

Female (n = 44)
32.82 (11.85)
165.56 (7.44)
66.92 (11.60)
24.44 (4.13)
4.12 (0.62)
7.05 (0.94)
173.47 (17.28)
525.17 (44.46)

Figure 1. Means and 95% confidence interval for the four measures of walking speed.
The calculated ICC (2,4) to determine agreement in walking speed for the four different measures was 0.90 (95% CI, 0.86-0.93)
and was classified as substantial using Shrout’s criteria. The correlation matrix for the relationships of the four measures is
presented in Figure 2. All correlations were significant (all p<0.05). The relationship between the 6MWT and 10MWT was quite
high (Pearson r = 0.94; 95% CI, 0.93-0.95). The relationship between the 2minWT and 6minWT) was also quite high (Pearson r =
0.95; 95% CI, 0.94-0.96).
Because the correlation coefficients between the two types of walking speed measures were high, Bland-Altman plots were created
(Figures 3 and 4). For both plots, the bias lines were close to zero, and the scatter points appeared random. The range between
the SD (±1.96 SD) was narrow, suggesting any bias between the four measures was probably not clinically important.
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Figure 2. Correlation matrix for the four different walking speed tests
*Denotes significance at an alpha levelof 0.5

Figure 3: Bland Altman Plot of 2-minute Walk Test versus 6 -minute Walk Test

Figure 4. Bland Altman Plot of 6-meter Walk Test with 10-meter Walk Test
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DISCUSSION
In the current study, no differences were found in walking speed between the four different tests (Figure 2). This finding suggests
that any of the four tests could be used in practice settings that have limited space to measure walking speed. Because walking
speed is considered the sixth vital sign, our results are important because they provide clinicians flexibility when choosing a test
that does not need to be adapted or modified to fit the clinician’s practice setting. 1,2 For example, if a clinic has limited space that
prevents the patient from being able to walk on a flat, straight walkway without turns for 10 meters, 6 meters, for 6 minutes or for
2 minutes then an appropriate walking test would need to be used for that practice setting meaning most outpatient clinics would
require the patient to be tested outside. The equipment needed for measuring walking speed between the four measures is minimal
and has utility in multiple settings.
For example, the 6minWT can be performed on a treadmill with distance measured in meters. In the current study, infrared sensors
were used to measure precise walking speed for our comparisons, but this equipment is not necessary for a clinical setting when
testing 6-meter or 10-meter walking speed. Clinically, both of these tests are measured by a stopwatch and although not as precise
as an infrared sensor, a stopwatch is inexpensive and an accurate measure for walking speed. In the current study, a Keson Metal
Professional measuring wheel was used to precisely measure the distance walked for the 2minWT and 6minWT. This inexpensive
device is ideal for clinicians who want to measure the precise distance walked. A recent study concluded the use of a measuring
wheel reflects physical performance more accurately because it measures turns that are incorporated into these measures more
accurately.32 In another study, researchers suggested that turns require adjustments in speed and increase the complexity of the
test, making it harder to standardize over multiple assessment sessions and between patients; therefore, any improvement in the
measurement of turns is beneficial.2 The authors of the current study mention turns because many of the clinical settings that use
these walking speed tests modify these tests and include multiple turns during the walking test.
Each of the four measures used to assess walking speed in the current study has ample evidence to support their use. However,
one study reported few physical therapists measure the walking speed of patients.22,33 Salbach et al noted that 32%-44% of physical
therapists reported testing walking speed even though it is considered vital information.34 Two other studies reported 11%-44% of
physical therapists measured walking distance.35,36 Perhaps this lack of assessment of walking speed or walking distance results
from time constraints of physical therapists across clinical settings or the medical complexity of patients with multiple comorbidities.
Others have suggested that muscle weakness, gait inefficiency, or poor endurance may contribute to the lack of assessment of
walking speed or distance tests.37,38
Because the 2minWT and 6minWT require the patient to walk a distance for the specified time, these tests may be inappropriate
for those patients who may be unable to complete the required distance. Therefore, we recommend that this potential limitation
should be considered before testing and that vital signs should be taken before testing any of the four measures to ensure patient
safety. Also the 6minWT may be too difficult for specific populations of patients. Authors suggest older adults are not able to walk
400 meters during the 6minWT.29,39 Steffen et al specifically noted that a walked distance of fewer than 300 meters in 6 minutes
predicted an increased likelihood of death in patients with left ventricular dysfunction. 40 Based on the results of the current study,
the 2minWT or the 10MWT may be better suited to estimate walking speed for patients unable to tolerate longer distances such
as the 6minWT, and it may be a more efficient way of measuring walking speed for the therapist limited by time constraints.
However, each clinician needs to decide which test and measurement method best suit the patient’s presentation and the patient’s
restrictions or impairments.
For example, in a patient with an endurance limitation, the 2minWT may be ideal, but if the clinician wants to measure endurance,
the 6minWT is better. In general, clinicians need tests that are efficient as well as reliable and valid, and walking speed is an
important measure that can be quickly assessed in multiple practice settings Middleton et al provide an excellent resource of
minimal detectable change differences for walking speed and walking distance across multiple populations.2
In the current study, no differences between sexes were found in walking speed across the four different tests. This finding
contradicts other studies investigating specific walking speed tests. In a systematic review, Salbach et al reported differences
between sexes and age for the 6minWT.34 The mean self-selected speed of males and females for that test were grouped by
decade, and males generally reported a higher walking speed than females for all age ranges (20-30 years up to 70-79 years).34
The authors also noted differences in walking speed for sex-specific age decades across four countries and for sex differences in
walking speed across the United States.34 However, no evidence of differences or similarities in sex across the other three
measures were found in that study.
When determining which of the four measures of walking speed should be used, the clinician should consider which test is best
for the specific patient population and how much space is available to perform the test. Amatachaya et al suggest that one limitation
© The Internet Journal of Allied Health Sciences and Practice, 2021
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of assessing walking speed is related to the available area and depends on the facility where the test occurs.3 Further, the number
of turns influences walking speed and distance, especially for patients with neurological disorders. Multiple studies have
recommended that, when using the 6minWT, the setting needs to have a rectangular walkway that is clear of obstacles to limit the
influence of the increased number of turns.18-20 Although there will be turns in tests that use a 4-meter to 10-meter walkway, a
rectangular walkway allows the patient to only have to turn 90° rather than 180°. Because this modification of the walking speed
test may change results, it requires more investigation in future studies. Researchers have also suggested that instruction and
encouragement during gait speed tests should be considered and rigorously standardized so that knowledge of performance and
results do not influence the patient’s gait speed.20 For instance, if clinicians want the patient to do well or improve over time, they
may unconsciously provide the patient with a feedback on performance during the test. The current study did not provide knowledge
of performance to participants, and we agree with the previous recommendation of rigorously standardizing each walking speed
test.
Limitations
The current study had several limitations. All four measures of walking speed were assessed in one continuous trial, and all testing
was done sequentially. There were several reasons why the study was performed this way. Since the study was conducted in a
warmer climate, we were concerned about the influence of increasing temperature, so we determined that all participants needed
to be tested in the morning. Testing was conducted when the outside temperature was between 70°F and 90°F (21°C and 32°C).
Although all participants were acclimated to this climate, the temperature may have influenced their performance. Testing was
completed outside over even ground, but this environment may be difficult to replicate for clinicians who test patients in different
clinical settings, such as a busy hospital hallway or inside or outside of a patient’s home. Because the current study investigated
healthy participants, our results may not apply to all patient populations. Therefore, clinicians need to select the most appropriate
test and measurement method that matches the patient population being tested. Given the results of the current study, we
encourage more physical therapists to assess walking speed than the 11%-44% who reported doing so.35,36 We especially
encourage increased use of this assessment because walking speed is well established in the literature and is considered the sixth
vital sign.1,2
CONCLUSIONS
The results of the current study suggested that the administration of any of the four walking tests would provide a reliable
measurement of walking speed. These findings are important and should be considered when clinicians determine the best test to
assess walking speed given the patient’s condition, the facility’s setting, and the equipment needed for measuring gait speed.
Walking speed for all individuals is important. For example, the amount of time it takes an individual to cross a street involves the
parameter of walking speed. Whether the patient has impairments such as an incomplete spinal cord injury, multiple sclerosis,
stroke, Parkinson’s disease, a total hip replacement, a total knee replacement, an ACL injury, low back pain, or other lower
extremity injury; the time to cross a street is set between 3 to 6 miles/hour by the Department of Transportation. The amount of
time to cross the street is not set to any specific patient population other than to the general population. Signals at crosswalks are
not changed to any specific population. The authors of the current study designed this study for the general population. The main
concern of the authors of the current study is how to address the hesitation by clinicians in measuring walking speed for their
patients. At this time, the five vital signs measured by clinicians are blood pressure, heart rate, respiratory rate, temperature, and
pain. The authors of the current study suggest that clinicians consider gathering some measure of walking speed, whether formally
(using a stopwatch and a specific distance) or informally (through observation) on patients seen for physical therapy. For example,
if a 30-year-old patient walks at a slow speed during a visit to his/her physician, the physician should note it and make an
appropriate referral. Not noting this impairment and not making the appropriate referral could be considered malpractice.
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